HBV-Related Conditions
Coverage of the 2013 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Wednesday, 30 October 2013 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 64th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2013) in Washington, DC, November 1-5, 2013.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
10/30/13
Coverage of the 2012 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 13 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2012) in Boston, November 9-13, 2012.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
HIVandHepatitis.com AASLD 2012 conference section
11/13/12
Hepatitis B Virus Infection Linked to Non-Hodgkin Lymphoma in South Korean Study
- Details
- Category: HBV-Related Conditions
- Published on Friday, 06 August 2010 12:49
- Written by Liz Highleyman
People with chronic hepatitis B virus (HBV) infection were almost twice as likely as uninfected individuals to develop non-Hodgkin lymphoma and certain other types of blood cell cancers, according to a large South Korean analysis described in the August 4, 2010 advance online edition of Lancet Oncology. Occurrence of lymphoma was uncommon overall, however, indicating that prevention and treatment of hepatitis B is unlikely to greatly affect lymphoma rates.
Lymphoma Chemotherapy Can Cause Severe Hepatitis B Reactivation
- Details
- Category: HBV-Related Conditions
- Published on Tuesday, 28 September 2010 12:46
- Written by Liz Highleyman
Chronic hepatitis B patients are at risk for recurrence or relapse when they undergo chemotherapy for lymphoma, despite receiving prophylaxis with lamivudine (Epivir-HBV), according to an Italian study presented at the recent 50th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2010) in Boston. Investigators recommended that other potentially more effective antiviral drugs should be studied for this indication.
Bone Loss and Vitamin D Deficiency Are Common among People with Liver Cirrhosis
- Details
- Category: Fibrosis & Cirrhosis
- Published on Tuesday, 01 September 2009 14:01
- Written by Liz Highleyman
People with liver cirrhosis -- a potential outcome of chronic hepatitis B or C -- frequently experience bone loss, or reduced bone mineral density (BMD), and often have low vitamin D levels, according to an Indian study published in the July 28, 2009 issue of World Journal of Gastroenterology.
Web Design and Development by